Antoni Krasinski

This inventor holds 37 USPTO granted patents and 6 published patent applications, plus 8 CIPO patents and 11 EPO patents, primarily in Chemokine Receptor Modulators. Top assignees: Chemocentryx, Inc., Amgen Inc.. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antoni Krasinski. Retrieved from https://idiyas.com/inventor/antoni-krasinski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 37 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 8 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 13)

Average Co-Inventor Count = 7.4

ph-index = 10

Forward Citations = 232(Granted Patents)

Location History:

San Jose, CA (US) (2012 - 2020)
Mountain View, CA (US) (2009 - 2022)
Sunnyvale, CA (US) (2017 - 2024)

Company Filing History:

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

Chemokine Receptors

CCR6 Inhibitors

C5aR Antagonists

Inflammation Treatment

Aza-Aryl Compounds

Heteroaryl Sulfonamides

Pyrrolidinone Derivatives

Fused Heteroaryl Pyridyl

Sulfonamides

Intermediates Preparation

Modulators

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12611404 - Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides (2026-04-28),

2. 12018016 - Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors (2024-06-25),

3. 11845729 - Processes and intermediates in the preparation of C5aR antagonists (2023-12-19),

4. 11834452 - CXCR7 antagonists (2023-12-05),

5. 11820759 - Modulators of chemokine receptors (2023-11-21),

6. 11684606 - Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2 (2023-06-27),

7. 11433061 - Heteroaryl sulfonamides and CCR2/CCR9 (2022-09-06),

8. 11254695 - Soluble C5aR antagonists (2022-02-22),

9. 11207294 - Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2 (2021-12-28),

10. 11059825 - CXCR7 antagonists (2021-07-13),

11. 11026935 - Free base crystalline form of a complement component C5a receptor (2021-06-08),

12. 10988464 - Modulators of chemokine receptors (2021-04-27),

13. 10899765 - Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation (2021-01-26),

14. 10596163 - Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides (2020-03-24),

15. 10532982 - Processes and intermediates in the preparation of C5aR antagonists (2020-01-14),

Title: Antoni Krasinski: Pioneering Inventor from Sunnyvale

Introduction: Antoni Krasinski is a renowned inventor based in Sunnyvale, California, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Antoni Krasinski holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Antoni Krasinski has worked with leading tech companies, spearheading projects that have revolutionized the industry. His innovative solutions have earned him recognition as a visionary in the field.

Collaborations: Throughout his career, Antoni Krasinski has collaborated with top researchers, engineers, and scientists to bring cutting-edge ideas to life. His ability to work in multidisciplinary teams has led to the development of groundbreaking technologies.

Conclusion: Antoni Krasinski's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and technologists. His impact on the tech industry is truly remarkable, solidifying his legacy as a pioneering figure in the world of inventions.

Profile summary based on public USPTO records.